GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thyrocare Technologies Ltd (NSE:THYROCARE) » Definitions » Quick Ratio

Thyrocare Technologies (NSE:THYROCARE) Quick Ratio : 2.55 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thyrocare Technologies Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Thyrocare Technologies's quick ratio for the quarter that ended in Mar. 2024 was 2.55.

Thyrocare Technologies has a quick ratio of 2.55. It generally indicates good short-term financial strength.

The historical rank and industry rank for Thyrocare Technologies's Quick Ratio or its related term are showing as below:

NSE:THYROCARE' s Quick Ratio Range Over the Past 10 Years
Min: 1.61   Med: 4.77   Max: 14.15
Current: 2.55

During the past 10 years, Thyrocare Technologies's highest Quick Ratio was 14.15. The lowest was 1.61. And the median was 4.77.

NSE:THYROCARE's Quick Ratio is ranked better than
60.94% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.9 vs NSE:THYROCARE: 2.55

Thyrocare Technologies Quick Ratio Historical Data

The historical data trend for Thyrocare Technologies's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thyrocare Technologies Quick Ratio Chart

Thyrocare Technologies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 2.28 3.80 3.18 2.55

Thyrocare Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.18 - 2.58 - 2.55

Competitive Comparison of Thyrocare Technologies's Quick Ratio

For the Diagnostics & Research subindustry, Thyrocare Technologies's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thyrocare Technologies's Quick Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thyrocare Technologies's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Thyrocare Technologies's Quick Ratio falls into.



Thyrocare Technologies Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Thyrocare Technologies's Quick Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Quick Ratio (A: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2785.1-475.2)/904.8
=2.55

Thyrocare Technologies's Quick Ratio for the quarter that ended in Mar. 2024 is calculated as

Quick Ratio (Q: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(2785.1-475.2)/904.8
=2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thyrocare Technologies  (NSE:THYROCARE) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Thyrocare Technologies Quick Ratio Related Terms

Thank you for viewing the detailed overview of Thyrocare Technologies's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Thyrocare Technologies (NSE:THYROCARE) Business Description

Traded in Other Exchanges
Address
D-37/1, TTC Industrial Area, MIDC, Turbhe, Opposite Sandoz, Navi Mumbai, MH, IND, 400703
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Other. The Diagnostic Testing Services segment provides a medical diagnostic investigation into thyroid disorders, metabolism disorders, diabetes, anemia, infertility, auto-immunity, and other infectious diseases. The company primarily earns majority of its revenue from Diagnostic Testing Services segment. The Imaging Services segment operates a network of imaging centers focused on early and effective cancer monitoring. The Other business segment provides miscellaneous services. The company earns the vast majority of its revenue in India.

Thyrocare Technologies (NSE:THYROCARE) Headlines

No Headlines